(lp0
S'Analyst Calls for Exponential Upside for Idera Pharmaceuticals Yahoo Finance - Mar 25, 2017 Idera Pharmaceuticals Inc.  is focused on cancer and rare diseases, and it could be a what traders refer to as a three-bagger or four-bagger, if two analysts who made key calls in recent days end up being correct here.Could Idera Pharmaceuticals Inc  Be Sitting On a Blockbuster - The Oracle Dispatch'
p1
aS"Idera Pharmaceuticals' Well-Funded And Growing Pipeline Of Potentially ... Seeking Alpha - Feb 27, 2017 Idera Pharmaceuticals  is a clinical-stage biopharmaceutical company developing novel nucleic acid based therapies for the treatment of certain cancers and rare diseases.Hot Stock to Watch: Idera Pharmaceuticals, Inc.  - HugoPressStock Movers  MannKind Corporation , Idera Pharmaceuticals Inc ... - Wall Street Times "
p2
aS'Why to Keeping Eye on Idera Pharmaceuticals, Inc. , CVS Health ... StockNewsJournal - 19 hours ago ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.'
p3
aS'The Technical Charts For Idera Pharmaceuticals, Inc.  Say It All Today NY Stock News - 18 hours ago The technicals for Idera Pharmaceuticals, Inc.  have taken shape, and with them a comprehensive picture has emerged.'
p4
aS'Idera Pharmaceuticals, Inc.  Stock Technicals are in the neutral area USA Commerce Daily - 13 hours ago With all other things going on, Idera Pharmaceuticals, Inc.  has been on a run - rising 63.46 percent in just three months.'
p5
aS"Idera Pharmaceuticals and XOMA Find Paths to Financial Growth Yahoo Finance - Mar 23, 2017 At Wednesday's close, XOMA Corporation found its stock scoot up $0.70 per share on Wednesday, to close at $6.045. The 13 percent increase was fueled by news that the company had fully prepaid its capital debt to Hercules Technology Growth, and it will&nbsp;..."
p6
aS'Zacks Provided 1 Rating to Idera Pharmaceuticals, Inc.  The Newburgh Press - 17 hours ago The 1-year price target of the company is 5. Investors expected a price target of -0.1 for this quarter. Zacks Investment Research gave Idera Pharmaceuticals, Inc.  a rating of 1 on a scale of 1 to 5. Here, 1 indicates a Strong Buy and 5 ...Idera Pharmaceuticals Inc.  Moves Higher on Volume Spike for March 27 - Equities.com16 hedge funds buy Idera Pharmaceuticals, Inc.  for the first time - Post Analyst'
p7
aS'Market View: Checking on the Technicals for Idera Pharmaceuticals, Inc ... The Standard - 15 hours ago Tracking shares of Idera Pharmaceuticals, Inc. , the company has a current EV  of 271175.'
p8
aS'Idera Pharmaceuticals  Looks Good: Stock Up 13.3% Yahoo Finance - Mar 1, 2017 Idera Pharmaceuticals, Inc. IDRA was a big mover last session, as the company saw its shares rise over 13% on the day.'
p9
aS"Idera Pharmaceuticals, Inc. closed with a change of 2.48% in the Previous ... Free Observer - Mar 27, 2017 If you look at the company's income statement over the past years, you will see that the company is constantly posting gross profit: In 2014, IDRA earned gross profit of 0, in 2015 0 gross profit, while in 2016 Idera Pharmaceuticals, Inc. (IDRA ...Idera Pharmaceuticals, Inc.  hit its 52 Week high of $3.33 on Sep 26, 2016 - The Newburgh PressPredictive Analysis for Idera Pharmaceuticals, Inc.  - The Oracle Examiner"
p10
a.